A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged β₯40 to β€85 Years With Chronic Obstructive Pulmonary Disease.
LPS18583 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 4 study with 2 treatment groups. The purpose of this study is to assess the effect…
Run by: Sanofi